GRN163L
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for GRN163L, covering 2015-12-24 to 2015-12-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies [Phase 1]